The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $77.5, a high ...

On Tuesday, May 27, an analyst from BTIG downgraded Globus Medical Inc. (NYSE:GMED) from Buy to Neutral, citing concerns about its Spine business. The analyst did not assign a price target following ...

BTIG analysts have downgraded (NYSE:GMED) from "Buy" to "Neutral" amid fears surrounding the company's Spine business.

Thornal will join the orthopedics company as group president for global businesses and the Americas, a newly created position ...

Chester County Futures (CCF), in collaboration with Globus Medical, recently provided a transformative learning experience ...

Zimmer Biomet announced today that it appointed Kevin Thornal as group president, global businesses and the Americas.

Samsung's venture arm is looking to invest in California-based medical device startup Exo, Bloomberg reported.